JMI Syringes & Medical Devices Limited

DSE:JMISMDL Stock Report

Market Cap: ৳4.7b

JMI Syringes & Medical Devices Past Earnings Performance

Past criteria checks 0/6

JMI Syringes & Medical Devices's earnings have been declining at an average annual rate of -36.9%, while the Medical Equipment industry saw earnings growing at 9.2% annually. Revenues have been growing at an average rate of 4.1% per year.

Key information

-36.9%

Earnings growth rate

-39.7%

EPS growth rate

Medical Equipment Industry Growth12.3%
Revenue growth rate4.1%
Return on equity-6.8%
Net Margin-10.0%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How JMI Syringes & Medical Devices makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DSE:JMISMDL Revenue, expenses and earnings (BDT Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 231,746-1751560
30 Sep 231,780-1671590
30 Jun 231,755-1501500
31 Mar 232,188381490
31 Dec 222,380661710
30 Sep 222,4671011780
30 Jun 222,4381011770
31 Mar 222,1961031630
31 Dec 212,084901580
30 Sep 212,071901500
30 Jun 211,994891510
31 Mar 212,031971620
31 Dec 202,0351031410
30 Sep 201,879871530
30 Jun 201,977961800
31 Mar 201,886931820
31 Dec 191,892942040
30 Sep 191,831831910
30 Jun 191,778671850
31 Mar 191,548831630
31 Dec 181,498821610
30 Sep 181,468781640
30 Jun 181,421751560
31 Mar 181,478751680
31 Dec 171,396721570
30 Sep 171,417741580
30 Jun 171,363751460
31 Mar 171,535801810
31 Dec 161,415711490
30 Sep 161,290671200
30 Jun 161,359711320
31 Mar 161,261561150
31 Dec 151,213531110
30 Sep 151,287521230
30 Jun 151,287521140
31 Mar 151,223501070
31 Dec 141,199491060
30 Sep 141,278491200
30 Jun 141,117461050
31 Mar 1492137870
31 Dec 1383932850
30 Sep 1366736750
30 Jun 1365116760

Quality Earnings: JMISMDL is currently unprofitable.

Growing Profit Margin: JMISMDL is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: JMISMDL is unprofitable, and losses have increased over the past 5 years at a rate of 36.9% per year.

Accelerating Growth: Unable to compare JMISMDL's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: JMISMDL is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-1.5%).


Return on Equity

High ROE: JMISMDL has a negative Return on Equity (-6.8%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.